Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Retained Earnings of -$48.5 million in Q1 2026, down 4.65% quarter-over-quarter from -$46.3 million in Q4 2025, and down 28.76% on a YoY basis from -$68.0 million in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Retained Earnings history runs 6 years deep, the most recent figure standing at -$48.5 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 28.76% year-over-year to -$48.5 million; the TTM figure through Mar 2026 stood at -$48.5 million (down 28.76% YoY), while the FY2025 annual figure was -$46.3 million, down 33.9% from the prior year.
- Retained Earnings was -$48.5 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from -$46.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$8.1 million in Q3 2022 to a low of -$48.5 million in Q1 2026.
- Historically, Retained Earnings has averaged -$29.3 million across 5 years, with a median of -$29.2 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Retained Earnings slumped 192.15% in 2023, then dropped 28.76% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$18.8 million in 2022, then tumbled by 34.99% to -$25.4 million in 2023, then tumbled by 35.96% to -$34.6 million in 2024, then sank by 33.9% to -$46.3 million in 2025, then declined by 4.65% to -$48.5 million in 2026.
- The last three Retained Earnings figures came in at -$48.5 million (Q1 2026), -$46.3 million (Q4 2025), and -$43.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | -48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.45 Mn |
| Dec 31, 2025 | -46.30 Mn |
| Sep 30, 2025 | -43.68 Mn |
| Jun 30, 2025 | -41.34 Mn |
| Mar 31, 2025 | -37.63 Mn |
| Dec 31, 2024 | -34.58 Mn |
| Sep 30, 2024 | -32.98 Mn |
| Jun 30, 2024 | -29.20 Mn |
| Mar 31, 2024 | -27.16 Mn |
| Dec 31, 2023 | -25.43 Mn |
| Sep 30, 2023 | -23.79 Mn |
| Jun 30, 2023 | -12.05 Mn |
| Mar 31, 2023 | -9.87 Mn |
| Dec 31, 2022 | -18.84 Mn |
| Sep 30, 2022 | -8.14 Mn |
| Dec 31, 2021 | -13.84 Mn |